Understanding Pain in Herpes Zoster: An Essential for Optimizing Treatment
|
|
- Kelly Phillips
- 6 years ago
- Views:
Transcription
1 S78 Understanding Pain in Herpes Zoster: An Essential for Optimizing Treatment Martin Wood Department of Infection and Tropical Medicine, Heartlands Hospital, Birmingham, United Kingdom After herpes zoster, immunocompetent persons frequently experience chronic pain and considerable suffering. Zoster-associated pain has a complex pathophysiology that begins with viral damage and increased sensitization of peripheral sensory neurons. The enhanced afferent barrage from these neurons sensitizes spinal neurons and leads to loss of synapses from descending inhibitory fibers, resulting in central neuropathic pain and allodynia. Antiviral therapy of acute zoster limits this sequence of pathophysiologic mechanisms. There is no clear consensus regarding the optimal means of determining the benefits of antiviral therapy in the management of pain of herpes zoster. A novel statistical approach utilizing rates of disappearace of pain of differing pathophysiologic mechanisms is proposed. Herpes zoster occurs when latent varicella-zoster virus (VZV) reactivates and multiplies within a sensory ganglion and travels along the sensory nerve to the skin. This is a common disease, particularly among the elderly. Epidemiologic data indicate there are cases per 1000 persons per year [1]. Pain is the most troublesome symptom of herpes zoster and the reason for most physician consultations. In a large observational trial of valacyclovir, pain preceded the rash of herpes zoster in 84% of patients and was present during the acute exanthem phase in 89% [2]. Pain preceding or accompanying the dermatomal rash is termed acute pain. In some persons, especially the elderly, pain in the distribution of the affected sensory nerve can persist for days, weeks, months, or occasionally years after the skin manifestations of the condition have resolved [3]. Traditionally this persisting chronic pain is termed postherpetic neuralgia (PHN) and is defined as pain persisting after the lesions have healed or pain persisting 4 weeks after the onset of lesions, regardless of degree of healing. Unlike pain accompanying acute tissue damage, which stimulates a person to avoid further damage to the area, persistent pain offers no biologic advantage and leads only to suffering and distress. As a result of activity in spinohypothalmic and pontine-hypothalamic pathways, the stress response is initiated and, once this stress response is extended it becomes dysregulated and maladaptive [4]. This leads to fatigue, impaired functioning, and adaptive behavior that is experienced as sickness. In turn, this promotes negative thinking and a vicious circle of stress and disability, rendering an individual incapable of performing as usual in the home, community, or workplace [4]. Thus, chronic pain is a major burden to the individual in Financial support: GlaxoSmithKline (honoraria). Reprints or correspondence: Dr. Martin Wood, Dept. of Infection and Tropical Medicine, Heartlands Hospital, Birmingham B9 5SS, United Kingdom (m.j.wood@bham.ac.uk). The Journal of Infectious Diseases 2002;186(Suppl 1):S by the Infectious Diseases Society of America. All rights reserved /2002/18608S-0010$15.00 terms of suffering and to the healthcare system and society at large. To consider the rationale behind the wide range of interventions that have been used in acute herpes zoster and to formulate optimal approaches, it is helpful to understand the pathophysiologic mechanisms that contribute to the pain associated with herpes zoster. In one patient it is impossible to determine the contribution of different pain mechanisms occurring simultaneously, but modeling of the kinetics of pain in a population that has experienced herpes zoster could enable a more rational approach and an improved effect of therapy for an individual patient. Pathophysiology of Pain in Herpes Zoster The pain of herpes zoster is a form of neuropathic pain that results from damage to the nervous system. It is a conscious sensation resulting from complex sensory processing within the highest levels of the central nervous system (CNS) [5]. Pain accompanying acute herpes zoster. The neuropathology and acute inflammation of acute herpes zoster are maximal within the dorsal root ganglion of the affected dermatome but extend peripherally along the length of the sensory nerve and sometimes proximally to the adjacent motor and sensory roots and the spinal cord. This damage to neurons caused by VZV replication in acute herpes zoster results in an increase in the sensitivity and responsiveness of nociceptors (peripheral sensitization) [6]. This is a consequence of the initial inflammatory response to neuronal destruction and an associated release of cytokines. Of importance, the pain of acute herpes zoster is not produced by stimulation of the high threshold sensory receptors (nociceptors) and the functionally specialized nerve fibers that transmit sensations after noxious stimuli. Central sensitization. Although peripheral sensitization is important in the generation of the acute pain of herpes zoster, it does not explain why the area of cutaneous hypersensitivity extends beyond the affected dermatome. Such allodynia or hyperalgesia results from central sensitization or changes in-
2 JID 2002;186 (Suppl 1) Pain Mechanisms and Treatment of Zoster S79 duced within the dorsal horn of the spinal cord as a consequence of the stimulation of nociceptors [7]. When sensory axons are injured during herpes zoster, there is a brief very high frequency discharge that causes long-lasting depolarization of the spinal neurons during which the response of the dorsal horn cell to all inputs is accentuated (termed wind-up) [6]. More prolonged neural dysfunction (or even death) of dorsal horn neurons could result from calcium entry following impulse-induced glutamate stimulation of N-methyl-d-aspartic acid receptors [8]. Any consequent reduction in disinhibition of dorsal horn cells might convert temporary central sensitization to a permanent state without the need for further nociceptor input. Pathologic changes contributing to prolonged pain. Several pathologic changes could contribute to prolonged or even indefinite pain after herpes zoster. One is the development of small neuronal sprouts as nerve growth factor. In the other, chemicals induce an attempt to regenerate the damaged peripheral axons. These sprouts, termed ectopic neural pacemaker nodules [9], are capable of prolonged spontaneous pain impulses that may contribute to the continual reinforcement of central sensitization and hyperexcitability of dorsal horn neurons. Deafferentation of dorsal horn neurons probably also plays a role in the pathogenesis of long-term central sensitization. As a cell loses its effective peripheral input (i.e., becomes deafferented), it compensates by becoming more excitable and increases the rate at which it spontaneously fires impulses in highfrequency bursts. The increased excitability eventually results in the cell responding to stimuli traveling in adjacent axons to nearby healthy cells within the spinal cord. This has the effect of enhancing the receptive field of the deafferented cell and their overreaction mimics the response to noxious stimuli. There is some neuropathologic evidence of the above mechanisms of pain, although only a few postmortem studies have looked specifically at patients who had herpes zoster. Striking atrophy of the dorsal horn was described in persons who had severe PHN but not in those without such pain [10]. This structural change may reflect loss of inhibitory fibers within the dorsal horn. Summary of pain mechanisms. In essence, the pain of herpes zoster results from a sequence of changes in neuronal sensitivity starting at the point of neural damage in the periphery and moving centrally to affect one cell after another within the pain pathway. Once central sensitization occurs, attempts to influence the pain purely by influencing peripheral nociceptor function are unlikely to be successful. Furthermore, once established, such neuropathic pain is notoriously difficult to control. Treatment of the acute illness is thus chiefly directed at minimizing the risk of the prolonged pain. The cascades of responses that lead to pain after acute neuronal injury occur very rapidly; neurotransmitter release within seconds, wind-up and sensitization within minutes, sprouting and remodeling within hours, and structural responses over days to months [11]. This means that every attempt must be made to reduce further neuronal damage as soon as is practicable in the course of the acute illness. It also impacts upon the way in which the pain resolution curve in a population with herpes zoster should be interpreted and analyzed (see below). Means of Reducing Chronic Pain and Other Complications in Herpes Zoster Steroids. Although in some well-controlled trials, corticosteroids were beneficial for acute zoster pain and allowed patients to return to normal activity more quickly, they do not affect the development or duration of PHN [12]. No evidence supports the use of oral nonsteroidal antiinflammatory agents in acute herpes zoster pain or PHN. Nerve blocks. Although there are numerous anecdotes (many dating back several decades) attesting to the efficacy of somatic or sympathetic nerve blocks for the relief of acute pain during herpes zoster [13], there are still no prospective largescale controlled studies of their efficacy in preventing PHN. Analgesics. It is good medical practice to provide adequate analgesia during the acute phase of herpes zoster and opioids impede transmission of nociception in the dorsal horn (among other actions). However, no data confirm that adequate analgesia for acute herpes zoster alters the development of PHN. Antidepressants. Tricyclic antidepressant drugs inhibit the reuptake of noradrenaline (norepinephrine) and serotonin in the CNS and are thought to increase the inhibition of nociceptive signals within the dorsal horn of the spinal cord. Often considered the mainstay of treatment of established PHN, their use as adjunctive therapy (with acyclovir) in acute herpes zoster was studied in a small trial [14]. Although the trial design was flawed (patients were warned that if they received amitriptyline they might observe dryness of the mouth and other side effects; hence the study was not truly double blind), the results indicated that early therapy with low-dose amitriptyline might reduce the prevalence of PHN. Antivirals. Since neuropathic pain mechanisms in herpes zoster begin very early after nerve damage, the most appropriate means of minimizing pain is prevention of further nerve damage by the use of antiviral drugs that stop VZV replication. Several nucleoside analogues have virologic benefits and improve cutaneous healing of acute herpes zoster, although their effects on PHN incidence or duration are less clear. The first drug with such efficacy in vitro that could be administered orally was acyclovir. Although the effect of acyclovir on PHN has been controversial (1 [15] of the 4 placebo-controlled studies [15 18] showed no benefit), a meta-analysis of all 4 studies showed oral acyclovir (800 mg 5 times/day) in acute herpes zoster reduced the duration of zoster-associated pain (ZAP), particularly in elderly patients (figure 1A) [19]. For more than 50 years, valacyclovir, the highly bioavailable prodrug of acyclovir, at a dosage of 1 g 3 times a day for 7 days, has been compared with acyclovir in patients with acute
3 S80 Wood JID 2002;186 (Suppl 1) Figure 1. Estimates of hazard ratios and 95% confidence intervals for meta-analysis of studies of treatments of herpes zoster by various pain milestones. A, Acyclovir vs. placebo (reproduced from [14]) and B, valacyclovir vs. acyclovir [15]. * PHN (postherpetic neuralgia), pain persisting 130 days after start of treatment; ** PHN, pain persisting after rash has healed; *** acute pain, pain in the first 30 days from treatment initiation. ZAP, zoster-associated pain. herpes zoster. The duration of pain from enrollment was significantly shorter in the valacyclovir recipients and a smaller proportion had pain persisting 6 months (19% vs. 26% of those given acyclovir; P p.02) [20]. Valacyclovir showed consistent advantages over acyclovir on a range of pain resolution milestones (figure 1B). The results of clinical trials of famciclovir (the orally absorbed prodrug of penciclovir) in herpes zoster showed that it was of at least equivalent clinical efficacy to acyclovir. In a placebo-controlled trial, famciclovir, 500 or 750 mg 3 times a day for 7 days, reduced the duration of pain after herpes zoster [21]. The effects on pain were compared by the median duration of PHN, defined as starting at the point of rash healing. Such data can be difficult to interpret (see below). In a comparative trial, famciclovir and acyclovir were of similar efficacy in the time to disappearance of pain, with certain subgroup analyses favoring famciclovir [22]. Intent-to-treat analyses of a randomized controlled trial of valacyclovir (1 g 3 times/day) or famciclovir (500 mg 3 times/ day) in immunocompetent patients aged 50 years with herpes zoster showed that the 2 drugs did not differ in their effects on resolution of ZAP or PHN, on rash healing, or in safety profiles [23]. In the United States and United Kingdom, current wholesale prices for a course of valacyclovir are considerably cheaper than the equivalent course of famciclovir, suggesting that valacyclovir is, at present, the more cost-effective option. No comparison of valacyclovir and the dosage of famciclovir licensed for treatment of herpes zoster in many European countries (250 mg 3 times/day) have yet been undertaken. Measurement of Pain Although persons who are still in pain from herpes zoster several months after the acute episode have a different quality of pain from that during the acute phase, these are the extremes of the pain continuum. In a percentage of the population (which probably depends on age), there will be sustained central hypersensitivity starting almost simultaneously with the acute pain. Furthermore, it is probable there is a subgroup of patients in whom central mechanisms are only slowly reversible (possibly as a result of pathologic changes): This too commences during the first few days or weeks of the acute illness. Hence, the pain present almost immediately from the outset in some persons with herpes zoster is caused by two or three different pathophysiologic mechanisms. The vast majority of patients with central hypersensitivity will also have acute pain; all with irreversible events in the dorsal horn cells will have a degree of less permanent central hypersensitivity. Each pain category will affect a different proportion of the population and each will decline naturally at different rates. Figure 2 illustrates the pain types. Although the various types of pain found in herpes zoster undoubtedly overlap, a person cannot describe the part played by each type in overall discomfort or determine when one type of pain ends. In population studies, the predominant pain at individual time points will influence the pain resolution curve. Clinical trials of antiviral therapies have attempted to assess their effect on the duration of pain. Usually the statistical analysis utilized is a Kaplan-Meier product limit method that estimates the distribution of time to cessation of pain in the population under study. The difficulty with this approach is in determining the effects of therapy upon the acute pain (peripheral mechanisms) compared with the chronic pain (central mechanisms). The dilemma in any such analysis is defining when acute pain ends and chronic pain (PHN) begins. The method traditionally used has been a phase-specific stratified analysis that defines PHN by one of two starting points: the time when skin lesions have healed (usually judged by either complete crusting of the lesions or loss of all crusts) or 4 weeks from onset of lesions, regardless of degree of healing. The dis-
4 JID 2002;186 (Suppl 1) Pain Mechanisms and Treatment of Zoster S81 Figure 2. Hypothetical model of pain of herpes zoster in a population. Acute pain is present in some persons before rash appears and disappears over a few weeks. Pain caused by sensitization of the central nervous system (CNS; reversible central pain) also starts very early in the course of herpes zoster but declines more slowly. Pain associated with pathologic changes in the CNS (established central pain) develops over a few weeks and declines very slowly. advantage of this approach is that the analysis of cessation of PHN will necessarily involve only a subset of the study population originally randomized, namely, those with persistent pain. This will lead to a reduction in the validity of the statistical analysis since any effects of treatment during the acute illness upon the factors that influence development of central pain mechanisms cannot be assessed. The cohort of patients with PHN is thus not likely to be of similar baseline characteristics. In particular, this will be the case if the point of rash healing defines PHN, yet one treatment group heals faster than another, or if one group has more patients whose pain ceases during the acute phase [24]. One suggestion to overcome this difficulty is to analyze pain as a continuum that starts at the onset of herpes zoster and lasts until the end of the follow-up period ( 6 months) [24]. This is a true intent-to-treat analysis that excludes any selection bias since it follows the original randomization scheme throughout. Analysis of the continuum of pain (ZAP), however, fails to determine whether there are treatment effects specific to the acute pain or chronic PHN. In order to clarify this matter, a proposal has been made to analyze the effects of antiviral therapy on specific phases of ZAP [25]. A recent classification of the pain associated with herpes zoster has divided the continuum of ZAP into three phases: acute herpetic neuralgia (any pain that persists up to 30 days from the onset of the rash), subacute herpetic neuralgia (pain present beyond day 30 that resolves within 4 months [120 days] of rash onset), and PHN (any pain persisting 120 days from onset of rash) [26]. It is tempting to equate these three phases with the three types of pain pathophysiology alluded to above. The proposed analysis [25] is piece-wise regression modeling of the hazard function followed by estimation of the two change points (where the ZAP curve changes its exponential decline owing to the predominance of a different type of pain). In this way the change points and hazard rates for specific phases and populations can be determined. The transition times in the classification suggested by Dworkin and Portenoy [26] were 30 and 120 days, but these would differ depending upon the proportion of persons in a particular population who develop central pain of one type or another. Arani et al. [25], the authors of the new analysis method, have also suggested use of log-survival function plots, which are linear in time, to visually detect differences in hazard rates (slopes) between treatment groups in specific phases of ZAP. Figure 3, for example, illustrates the survival function in which groups differ only in the acute phase. The traditional phase-specific stratification (figure 3A) might lead to the erroneous conclusion that the survival functions are distinct in the PHN phases. The corresponding log-survival plot (figure 3B), however, shows that the functions are parallel in phases 2 and 3, indicating equivalent hazard rates. Figure 3. Plot of survival (A) and log-survival functions (B) of 3 phases of zoster-associated pain for 2 groups. In group B, pain in phase 1 settles more rapidly but the slopes in phases 2 and 3 remain the same as for group A. This is not clearly evident from the traditional phasespecific stratification (B) but the log-survival functions are parallel in phases 2 and 3, indicating equivalent hazard rates.
5 S82 Wood JID 2002;186 (Suppl 1) Use of a model such as that discussed addresses the central issues of pain in herpes zoster and enables pain to be better defined in different populations. It also enables determination of whether therapy during the acute phase of herpes zoster will merely change the proportion of those who develop central pain and PHN or whether therapy will alter the speed with which such pain resolves long after the intervention has been removed. References 1. Wood MJ. Herpes zoster in the normal and immunocompromised host. In: Arvin AM, ed. Herpes virus infections. London: BallièreTindall,1996: Decroix J, Partsch H, Gonzalez R, et al. Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. J Eur Acad Dermatol Venereol 2000;14: Wood MJ. Herpes zoster and pain. Scand J Infect Dis Suppl 1991;80: Chapman CR, Gavrin J. Suffering: the contributions of persistent pain. Lancet 1999;353: Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353: Woolf CJ. Generation of acute pain: central mechanisms. Br Med Bull 1991;47: Wall PD. Neuropathic pain and injured nerve: central mechanisms. Br Med Bull 1991;47: Sugimoto T, Bennett GJ, Kajander KC. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction. Pain 1990;42: Devor M. Neuropathic pain and injured nerve: peripheral mechanisms. Br Med Bull 1991;47: Watson CP, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991;44: Carr DB, Goudas LC. Acute pain. Lancet 1999;353: Kost RG, Straus SE. Drug therapy: postherpetic neuralgia pathogenesis, treatment, and prevention. N Engl J Med 1996;335: Portenoy RK, Duma C, Foley KM. Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol 1986;20: Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized double-blind placebo-controlled trial. J Pain Symptom Manage 1997;13: Wood MJ, Ogan PH, McKendrick MW, Care CD, McGill JI, Webb EM. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 1988;85(Suppl 2A): Huff JC, Bean B, Balfour HH, et al. Therapy of herpes zoster with oral acyclovir. Am J Med 1988;85(Suppl 2A): Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. N Z Med J 1989;102: Harding SP, Porter SM. Oral acyclovir in herpes zoster ophthalmicus. Curr Eye Res 1991;10(Suppl): Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a metaanalysis of placebo-controlled trials. Clin Infect Dis 1996;22: Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995;39: Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. Ann Intern Med 1995;123: Degreef H, Famciclovir Herpes Zoster Clinical Study Group. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Int J Antimicrob Agents1994;4: Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 2000;9: Wood MJ, the Herpes Zoster Clinical Trials Consensus Group. How should zoster trials be conducted? J Antimicrob Chemother 1995;36: Arani RB, Soong SJ, Weiss HL, et al. Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat Med 2001;20: Dworkin RH, Portenoy RK. Proposed classification of herpes zoster pain. Lancet 1994;343:1648.
Clinical Applications for Change-Point Analysis of Herpes Zoster Pain
510 Journal of Pain and Symptom Management Vol. 23 No. 6 June 2002 Original Article Clinical Applications for Change-Point Analysis of Herpes Zoster Pain Renee A. Desmond, PhD, Heidi L. Weiss, PhD, Ramin
More informationMarch 1, 2006 Table of Contents. What is the best treatment for patients with an outbreak of herpes zoster?
March 1, 2006 Table of Contents FPIN's Clinical Inquiries Treatment of Herpes Zoster Clinical Question What is the best treatment for patients with an outbreak of herpes zoster? Evidence-Based Answer Resolution
More informationSeizure: the clinical manifestation of an abnormal and excessive excitation and synchronization of a population of cortical
Are There Sharing Mechanisms of Epilepsy, Migraine and Neuropathic Pain? Chin-Wei Huang, MD, PhD Department of Neurology, NCKUH Basic mechanisms underlying seizures and epilepsy Seizure: the clinical manifestation
More informationDiagnosis and Treatment of Postherpetic Neuralgia
J KMA Special Issue Diagnosis and Treatment of Postherpetic Neuralgia Myung Ha Yoon, MD Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School E mail : mhyoon@jnu.ac.kr
More informationApplied Education and Training, (PAAET).
175 Prednisolone can Prevent Post-Herpetic Neuralgia in Post-Kidney Transplant Recipient Mohammad Ahmed Saraya 1, Mariam Abdulrhman Al-Fadhli 2 and Jafar Abdulrida Qasem 3 1 Department of Tropical Medicine,
More informationSpinal Cord Injury Pain. Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018
Spinal Cord Injury Pain Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018 Objectives At the conclusion of this session, participants should be able to: 1. Understand the difference between nociceptive
More informationAntiviral treatment for shingles and its complications in immunocompetent adults
Quality Improvement Scotland In response to an enquiry from NHS Greater Glasgow & Clyde Number 21 January 2008 Antiviral treatment for shingles and its complications in immunocompetent adults Description
More informationIt has been estimated that 90% of individuals
Famciclovir for Cutaneous Herpesvirus Infections: An Update and Review of New Single-Day Dosing Indications Manju Chacko, MD; Jeffrey M. Weinberg, MD Infections with herpes simplex virus (HSV) types 1
More informationHerpes zoster. Diagnosis, Complications, Treatment, Prevention 서울대학교병원 FM R2 임하연
Herpes zoster Diagnosis, Complications, Treatment, Prevention 2018.04.14 서울대학교병원 FM R2 임하연 1 2 Overview reactivation of lat ent VZV along sensory nerve VZV(varicella-zoster virus) Human herpes virus-3
More informationChickenpox: The Varicella Zoster Virus 2.0 Contact Hours Presented by: CEU Professor
Chickenpox: The Varicella Zoster Virus 2.0 Contact Hours Presented by: CEU Professor 7 www.ceuprofessoronline.com Copyright 8 2007 The Magellan Group, LLC All Rights Reserved. Reproduction and distribution
More informationGRALISE (gabapentin) oral tablet
GRALISE (gabapentin) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage
More informationSubunit adjuvanted zoster vaccine: why the fuss?
Subunit adjuvanted zoster vaccine: why the fuss? Soren Gantt, MD PhD MPH Pediatric Infectious Diseases Vaccine Evaluation Center BC Children s Hospital University of British Columbia Disclosures Research
More informationA Mixed Model for Factors Predictive of Pain in AIDS Patients with Herpes Zoster
410 Journal of Pain and Symptom Management Vol. 17 No. 6 June 1999 Original Article A Mixed Model for Factors Predictive of Pain in AIDS Patients with Herpes Zoster Renée A. Harrison, PhD, Seng-jaw Soong,
More informationCondition: Herpes Zoster Ophthalmicus (HZO)
Condition: Herpes Zoster Ophthalmicus (HZO) Description: Herpes zoster represents a reactivation of the varicella zoster virus (VZV) which leads to characteristic skin lesions and, in many cases, ocular
More informationPharmacotherapy for herpes zoster
Managing Herpes Zoster and Postherpetic Neuralgia Katherine E. Galluzzi, DO, CMD Treatment strategies for herpes zoster infection include limiting viral replication with anti-infective agents as well as
More informationHerpes zoster results from reactivation
Herpes Zoster Pathogenesis and Cell-Mediated Immunity and Immunosenescence Michael N. Oxman, MD Herpes zoster, or shingles, is a localized disease characterized by unilateral radicular pain and a vesicular
More informationPAIN MANAGEMENT in the CANINE PATIENT
PAIN MANAGEMENT in the CANINE PATIENT Laurie Edge-Hughes, BScPT, MAnimSt (Animal Physio), CAFCI, CCRT Part 1: Laurie Edge-Hughes, BScPT, MAnimSt (Animal Physio), CAFCI, CCRT 1 Pain is the most common reason
More informationCase Information: DORSAL ROOT GANGLION SPINAL CORD STIMULATION & POST HERPETIC NEURALGIA (PHN)
Author Information Full Names: Dipan Patel, MD Corey Hunter, MD Affiliation: Dipan Patel, MD: Garden State Pain Control, Clifton, New Jersey, USA Corey Hunter, MD Attending Pain Physician, Ainsworth Institute
More informationBrian Kahan, D.O. FAAPMR, DABPM, DAOCRM, FIPP Center for Pain Medicine and Physiatric Rehabilitation 2002 Medical Parkway Suite 150 Annapolis, MD
Brian Kahan, D.O. FAAPMR, DABPM, DAOCRM, FIPP Center for Pain Medicine and Physiatric Rehabilitation 2002 Medical Parkway Suite 150 Annapolis, MD 1630 Main Street Suite 215 Chester, MD 410-571-9000 www.4-no-pain.com
More informationIntroduction to some interesting research questions: Molecular biology of the primary afferent nociceptor
Introduction to some interesting research questions: Molecular biology of the primary afferent nociceptor NOCICEPTORS ARE NOT IDENTICAL PEPTIDE SubP/CGRP Trk A NON-PEPTIDE IB4 P2X 3 c-ret Snider and McMahon
More informationClinical efficacy and tolerability of valacyclovir versus acyclovir in treatment of herpes zoster
Original Article Clinical efficacy and tolerability of valacyclovir versus acyclovir in treatment of herpes zoster Arun Achar, MD 1 Partha Pratim Chakraborty, MD 2 Tarapada Ghosh, MD 3 Biswanath Naskar,
More informationCHAPTER 4 PAIN AND ITS MANAGEMENT
CHAPTER 4 PAIN AND ITS MANAGEMENT Pain Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Types of Pain
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Sydney, Australia 2007 Hosted by: Next WSAVA Congress REDUCING THE PAIN FACTOR AN UPDATE ON PERI-OPERATIVE ANALGESIA Sandra Forysth, BVSc DipACVA Institute of Veterinary,
More informationJane is not alone. Each year, about 1 million US residents. Battling shingles: Fine-tune your care
Battling shingles: Fine-tune your care Which of the 3 antiviral agents works best for accelerating rash healing and reducing pain? And what about corticosteroids are they a good idea, or not? Read on.
More informationBy the end of this lecture the students will be able to:
UNIT VII: PAIN Objectives: By the end of this lecture the students will be able to: Review the concept of somatosensory pathway. Describe the function of Nociceptors in response to pain information. Describe
More informationPharmacology of Pain Transmission and Modulation
Pharmacology of Pain Transmission and Modulation 2 Jürg Schliessbach and Konrad Maurer Nociceptive Nerve Fibers Pain is transmitted to the central nervous system via thinly myelinated Aδ and unmyelinated
More informationSomatosensation. Recording somatosensory responses. Receptive field response to pressure
Somatosensation Mechanoreceptors that respond to touch/pressure on the surface of the body. Sensory nerve responds propotional to pressure 4 types of mechanoreceptors: Meissner corpuscles & Merkel discs
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
Amar PP,, 2014; Volume 3(3): 123-127 INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE A REVIEW ON HERPES ZOSTER AMAR PP 1, AJINKYA C 2, TOHID NB 2, ROHIDAS P 2, AVINASH C 2 1. Assistant
More informationZoster Vaccine for Older Adults
BC Centre for Disease Control IMMUNIZATION FORUM 29 Zoster Vaccine for Older Adults Michael N. Oxman, M.D. Professor of Medicine and Pathology University of California, San Diego VASDHS Staff Physician
More informationPain Pathways. Dr Sameer Gupta Consultant in Anaesthesia and Pain Management, NGH
Pain Pathways Dr Sameer Gupta Consultant in Anaesthesia and Pain Management, NGH Objective To give you a simplistic and basic concepts of pain pathways to help understand the complex issue of pain Pain
More informationPathophysiological Classification of Pain
PATHOPHYSIOLOGY Overview Pathophysiological Classification of Pain Central sensitization/ dysfunctional pain Nociceptive pain - Somatic - Visceral Multiple pain mechanisms may coexist (mixed pain) Neuropathic
More informationMYOFASCIAL PAIN. Dr. Janet Travell ( ) credited with bringing MTrPs to the attention of healthcare providers.
Myofascial Trigger Points background info Laurie Edge-Hughes BScPT, MAnimSt (Animal Physio), CAFCI, CCRT History lesson Dr. Janet Travell (1901 1997) credited with bringing MTrPs to the attention of healthcare
More informationReceptors and Neurotransmitters: It Sounds Greek to Me. Agenda. What We Know About Pain 9/7/2012
Receptors and Neurotransmitters: It Sounds Greek to Me Cathy Carlson, PhD, RN Northern Illinois University Agenda We will be going through this lecture on basic pain physiology using analogies, mnemonics,
More informationSYLLABUS SPRING 2011 COURSE: NSC NEUROBIOLOGY OF PAIN
SYLLABUS NSC 4358 NEUROBIOLOGY OF PAIN SPRING 2011 1 SYLLABUS SPRING 2011 COURSE: NSC 4358 001 NEUROBIOLOGY OF PAIN Instructor: Aage R. Møller PhD E-mail: AMOLLER@UTDALLAS.EDU Class schedule: Main Campus:
More informationHerpes Zoster: Description of the Associated Burden and Its Preventive Strategies
Herpes Zoster: Description of the Associated Burden and Its Preventive Strategies Pierre-Olivier Lang Department of Internal Medicine, Rehabilitation and Geriatrics, Hospital of Trois-Chêne Chemin du Pont-Bochet,
More informationCancer-induced bone pain
Cancer-induced bone pain Common Prevalent in particular cancers: breast (73%), prostate (68%), thyroid (42%), lung (36%), renal (35%), colon (5%) Correlates with an increased morbidity Reduced performance
More informationPain and endometriosis: How to optimize the medical management?
Pre-congress course Endometriosis sand pelvic pain 1st Society for endometriosis and uterine Disorders Meeting Paris, 7-9 May 2015 Pain and endometriosis: How to optimize the medical management? J. FAIDHERBE
More informationSTUDY. Incidence of Postherpetic Neuralgia After Combination Treatment With Gabapentin and Valacyclovir in Patients With Acute Herpes Zoster
ONLINE FIRST STUDY Incidence of Postherpetic Neuralgia After Combination Treatment With Gabapentin and Valacyclovir in Patients With Acute Herpes Zoster Open-label Study Whitney Lapolla, MD; Catherine
More informationDisseminated shingles acyclovir
Disseminated shingles acyclovir The Borg System is 100 % Disseminated shingles acyclovir Two developed disseminated herpes zoster, one developed cytomegalovirus. Reduced response to acyclovir,. Disseminated
More informationSensory coding and somatosensory system
Sensory coding and somatosensory system Sensation and perception Perception is the internal construction of sensation. Perception depends on the individual experience. Three common steps in all senses
More informationPain. Pain. Pain: One definition. Pain: One definition. Pain: One definition. Pain: One definition. Psyc 2906: Sensation--Introduction 9/27/2006
Pain Pain Pain: One Definition Classic Paths A new Theory Pain and Drugs According to the international Association for the Study (Merskey & Bogduk, 1994), Pain is an unpleasant sensory and emotional experience
More informationProf Dr Najlaa Fawzi
1 Prof Dr Najlaa Fawzi is an acute highly infectious disease, characterized by vesicular rash, mild fever and mild constitutional symptoms. is a local manifestation of reactivation of latent varicella
More informationChapter 11 Introduction to the Nervous System and Nervous Tissue Chapter Outline
Chapter 11 Introduction to the Nervous System and Nervous Tissue Chapter Outline Module 11.1 Overview of the Nervous System (Figures 11.1-11.3) A. The nervous system controls our perception and experience
More informationSomatic Sensation (MCB160 Lecture by Mu-ming Poo, Friday March 9, 2007)
Somatic Sensation (MCB160 Lecture by Mu-ming Poo, Friday March 9, 2007) Introduction Adrian s work on sensory coding Spinal cord and dorsal root ganglia Four somatic sense modalities Touch Mechanoreceptors
More informationLesson 33. Objectives: References: Chapter 16: Reading for Next Lesson: Chapter 16:
Lesson 33 Lesson Outline: Nervous System Structure and Function Neuronal Tissue Supporting Cells Neurons Nerves Functional Classification of Neuronal Tissue Organization of the Nervous System Peripheral
More informationINTERACTIVE QUESTIONS
INTERACTIVE QUESTIONS Pathophysiology What is pain? Pathophysiology Does everyone feel pain the same way? Pathophysiology From a practical point of view, how do you classify pain? Pathophysiology What
More informationNeurons Chapter 7 2/19/2016. Learning Objectives. Cells of the Nervous System. Cells of the Nervous System. Cells of the Nervous System
Learning Objectives Neurons Chapter 7 Identify and describe the functions of the two main divisions of the nervous system. Differentiate between a neuron and neuroglial cells in terms of structure and
More informationAcute Pain NETP: SEPTEMBER 2013 COHORT
Acute Pain NETP: SEPTEMBER 2013 COHORT Pain & Suffering an unpleasant sensory & emotional experience associated with actual or potential tissue damage, or described in terms of such damage International
More informationPain. Types of Pain. Types of Pain 8/21/2013
Pain 1 Types of Pain Acute Pain Complex combination of sensory, perceptual, & emotional experiences as a result of a noxious stimulus Mediated by rapidly conducting nerve pathways & associated with increased
More informationProf Wayne Derman MBChB,BSc (Med)(Hons) PhD, FFIMS. Pain Management in the Elite Athlete: The 2017 IOC Consensus Statement
Prof Wayne Derman MBChB,BSc (Med)(Hons) PhD, FFIMS Pain Management in the Elite Athlete: The 2017 IOC Consensus Statement 2 as 20 Experts published and leaders in their respective field 12 month lead in
More information211MDS Pain theories
211MDS Pain theories Definition In 1986, the International Association for the Study of Pain (IASP) defined pain as a sensory and emotional experience associated with real or potential injuries, or described
More informationPain teaching. Muhammad Laklouk
Pain teaching Muhammad Laklouk Definition Pain An unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage. Sensory (discriminatiory)
More informationOverview of Neuropathic pain
Overview of Neuropathic pain Kongkiat Kulkantrakorn,M.D. Neurology division Thammasat University 1 Contents Overview of pain New concepts and mechanism Treatment options New data in management 2 3 Breaking
More informationAnesthesiology, V 92, No 3, Mar 2000
691 Anesthesiology 2000; 92:691 8 2000 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Heterogenous Patterns of Sensory Dysfunction in Postherpetic Neuralgia Suggest Multiple
More informationMechanism of Pain Production
Mechanism of Pain Production Pain conducting nerve fibers are small myelinated (A-delta) or unmyelinated nerve fibers (C-fibers). Cell bodies are in the dorsal root ganglia (DRG) or sensory ganglia of
More informationChapter 16. Sense of Pain
Chapter 16 Sense of Pain Pain Discomfort caused by tissue injury or noxious stimulation, and typically leading to evasive action important /// helps to protect us lost of pain in diabetes mellitus = diabetic
More informationNMDA-Receptor Antagonists and Opioid Receptor Interactions as Related to Analgesia and Tolerance
Vol. 19 No. 1(Suppl.) January 2000 Journal of Pain and Symptom Management S7 Proceedings Supplement NDMA-Receptor Antagonists: Evolving Role in Analgesia NMDA-Receptor Antagonists and Opioid Receptor Interactions
More informationVARICELLA. Dr Louise Cooley Royal Hobart Hospital
VARICELLA Dr Louise Cooley Royal Hobart Hospital Varicella Zoster Virus (VZV): The Basics Herpes virus Exclusively human infection Primary infection: varicella (chickenpox) Neurotropic, establishing latency
More informationSupplementary Materials. Determining the optimal vaccination schedule for herpes zoster: a cost-effectiveness analysis.
Supplementary Materials Determining the optimal vaccination schedule for herpes zoster: a cost-effectiveness analysis. Phuc Le, PhD, MPH and Michael B. Rothberg, MD, MPH. Long term efficacy of the live
More informationTRANSCUTANEOUS ELECTRICAL STIMULATION
TRANSCUTANEOUS ELECTRICAL STIMULATION Transcutaneous electrical stimulation (TENS) Transcutaneous electrical stimulation ; An electronic device that produces electrical signals used to stimulate nerve
More informationSomatosensory Physiology (Pain And Temperature) Richard M. Costanzo, Ph.D.
Somatosensory Physiology (Pain And Temperature) Richard M. Costanzo, Ph.D. OBJECTIVES After studying the material of this lecture the student should be familiar with: 1. The relationship between nociception
More informationGENERAL PAIN DEFINITIONS
I. OVERVIEW GENERAL PAIN DEFINITIONS Charles E. Argoff, MD CHAPTER 1 1. What is pain? Some dictionaries define pain as An unpleasant sensation, occurring in varying degrees of severity as a consequence
More informationCase Report Varicella-Zoster-Mediated Radiculitis Reactivation following Cervical Spine Surgery: Case Report and Review of the Literature
Hindawi Publishing Corporation Case Reports in Infectious Diseases Volume 2013, Article ID 647486, 5 pages http://dx.doi.org/10.1155/2013/647486 Case Report Varicella-Zoster-Mediated Radiculitis Reactivation
More informationVol.22, ,500 mg day 7 1. NSAIDs. NSAIDs.
VZV Ramsay-Hunt Vol.22, 2015 I 2 1 65 2014 3 3 12 12 13 NSAIDs 13 14 1 2 3 2015 4 7 2015 6 22 J-STAGE 2015 9 25 567-0801 1-1-41 E-mail esenba@wakayama-med.ac.jp 17 X MRI 1 2 18 1,500 mg day 7 1 NSAIDs
More informationChapter Six Review Sections 1 and 2
NAME PER DATE Chapter Six Review Sections 1 and 2 Matching: 1. afferent nerves 2. autonomic nervous system 3. cell body 4. central nervous system (CNS) 5. dendrites 6. efferent nerves 7. myelin sheath
More informationPain Mechanisms. Prof Michael G Irwin MD, FRCA, FANZCA FHKAM Head Department of Anaesthesiology University of Hong Kong. The Somatosensory System
ain Mechanisms rof Michael G Irwin MD, FRCA, FANZCA FHKAM Head Department of Anaesthesiology University of Hong Kong The Somatosensory System Frontal cortex Descending pathway eriaqueductal gray matter
More informationThe anatomy and physiology of pain
The anatomy and physiology of pain Charlotte E Steeds Abstract Pain is an unpleasant experience that results from both physical and psychological responses to injury. A complex set of pathways transmits
More informationNeuropathic Pain in Palliative Care
Neuropathic Pain in Palliative Care Neuropathic Pain in Advanced Cancer Affects 40% of patients Multiple concurrent pains are common Often complex pathophysiology with mixed components Nocioceptive Neuropathic
More informationChronic pain: We should not underestimate the contribution of neural plasticity. *Gwyn N Lewis 1, David A Rice 1,2
Chronic pain: We should not underestimate the contribution of neural plasticity *Gwyn N Lewis 1, David A Rice 1,2 1 Health and Rehabilitation Research Institute, AUT University, Auckland, New Zealand 2
More informationPeripheral Subcutaneous Field Stimulation
Peripheral Subcutaneous Field Stimulation Policy Number: 7.01.139 Last Review: 9/2014 Origination: 7/2013 Next Review: 1/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide
More informationUsefulness of Inflammatory Markers for the Prediction of Postherpetic Neuralgia in Patients with Acute Herpes Zoster
JY Kim, et al pissn 1013-9087ㆍeISSN 2005-3894 Ann Dermatol Vol. 30, No. 2, 2018 https://doi.org/10.5021/ad.2018.30.2.158 ORIGINAL ARTICLE Usefulness of Inflammatory Markers for the Prediction of Postherpetic
More informationCHAPTER 4 PAIN AND ITS MANAGEMENT
CHAPTER 4 PAIN AND ITS MANAGEMENT Pain Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Types of Pain
More informationObjectives. VZV breaks out of the nerve cell body and travels down the nerve axons causing an infection of the skin in the region of the nerve
Deena B. Hollingsworth MSN, FNP-BC ENT Specialists of Northern Virginia Falls Church, Virginia Objectives Describe common signs and symptoms of herpes zoster Discuss the pathophysiology and diagnosis of
More informationTo provide guidance on prevention and control of illness caused by varicella-zoster virus (VZV).
Effective Date: 04/18 Replaces: 0 4 / 1 3 / 1 7 Page 1 of 4 POLICY: To provide guidance on prevention and control of illness caused by varicella-zoster virus (VZV). DEFINITIONS Two syndromes occur from
More informationWhat is Pain? An unpleasant sensory and emotional experience associated with actual or potential tissue damage. Pain is always subjective
Pain & Acupuncture What is Pain? An unpleasant sensory and emotional experience associated with actual or potential tissue damage. NOCICEPTION( the neural processes of encoding and processing noxious stimuli.)
More informationVARICELLA. Infectious and Tropical Pediatric Division, Department of Child Health, Medical Faculty, University of Sumatera Utara
VARICELLA (Chicken pox) Infectious and Tropical Pediatric Division, Department of Child Health, Medical Faculty, University of Sumatera Utara Definition : Varicella is a common contagious disease caused
More informationChapter 12 Nervous Tissue. Copyright 2009 John Wiley & Sons, Inc. 1
Chapter 12 Nervous Tissue Copyright 2009 John Wiley & Sons, Inc. 1 Terms to Know CNS PNS Afferent division Efferent division Somatic nervous system Autonomic nervous system Sympathetic nervous system Parasympathetic
More informationWe are IntechOpen, the first native scientific publisher of Open Access books. International authors and editors. Our authors are among the TOP 1%
We are IntechOpen, the first native scientific publisher of Open Access books 3,350 108,000 1.7 M Open access books available International authors and editors Downloads Our authors are among the 151 Countries
More informationNeuropathic pain, pain matrix dysfunction, and pain syndromes
Neuropathic pain, pain matrix dysfunction, and pain syndromes MSTN121 - Neurophysiology Session 3 Department of Myotherapy Session objectives Describe the mechanism of nociceptive chronic pain. Define
More informationHerpes Simplex Viruses: Disease Burden. Richard Whitley The University of Alabama at Birmingham Herpes Virus Infection and Immunity June 18-20, 2012
Herpes Simplex Viruses: Disease Burden Richard Whitley The University of Alabama at Birmingham Herpes Virus Infection and Immunity June 18-20, 2012 Mucocutaneous HSV Infections Life-Threatening HSV Diseases
More informationIntroduction to Neurobiology
Biology 240 General Zoology Introduction to Neurobiology Nervous System functions: communication of information via nerve signals integration and processing of information control of physiological and
More informationLearning Modules - Medical Gross Anatomy Nervous System Overview - Page 1 of 14
Nervous System Overview - Page 1 of 14 Overview of the Nervous System Every minute of every day, your nervous system is sending and receiving countless messages about what is happening both inside and
More informationUnit 2 Multiple Choice test
Name: Date: 1. Resting potential is to action potential as is to. A) adrenal gland; pituitary gland B) sensory neuron; motor neuron C) temporal lobe; occipital lobe D) polarization; depolarization E) dendrite;
More informationSpecial Issue on Pain and Itch
Special Issue on Pain and Itch Title: Recent Progress in Understanding the Mechanisms of Pain and Itch Guest Editor of the Special Issue: Ru-Rong Ji, PhD Chronic pain is a major health problem world-wide.
More informationUpdate on the Neurophysiology of Pain Transmission and Modulation: Focus on the NMDA-Receptor
S2 Journal of Pain and Symptom Management Vol. 19 No. 1(Suppl.) January 2000 Proceedings Supplement NMDA-Receptor Antagonists: Evolving Role in Analgesia Update on the Neurophysiology of Pain Transmission
More informationEmerging Issues in Reactivated Herpes Zoster Disease
Emerging Issues in Reactivated Herpes Zoster Disease Tim Hilderman, MD FRCPC 2018 Infection Prevention and Control Across the Continuum Friday, June 22 nd, 2018 DISCLOSURE STATEMENT Type of relationship
More informationBackground Rationale for resource
Background The Joint Committee on Vaccination and Immunisation 1 reviewed all the available medical, epidemiological and economic evidence as well as vaccine safety and efficacy relevant to offering a
More informationPathophysiology of Pain
Pathophysiology of Pain Wound Inflammatory response Chemical mediators Activity in Pain Path PAIN http://neuroscience.uth.tmc.edu/s2/chapter08.html Chris Cohan, Ph.D. Dept. of Pathology/Anat Sci University
More informationShingles Prevention. Dr. JS Reid March 2014
Shingles Prevention Dr. JS Reid March 2014 1 Conflict of interest In the past I have received support for vaccine work, clinical trials, presentation of papers and conference attendance from NZ Ministry
More informationPAIN MANAGEMENT. It is important to know as much about the man who has pain as it is to know about pain the man has Quote by Macnab et al
PAIN MANAGEMENT It is important to know as much about the man who has pain as it is to know about pain the man has Quote by Macnab et al DEFINATION OF PAIN International Association for the study of pain
More informationBiological Psychology. Key Point for this Unit: Everything psychological is simultaneously biological!!
Biological Psychology Key Point for this Unit: Everything psychological is simultaneously biological!! NEURON Dendrites Dendrites receive messages from other cells and conduct impulses toward the cell
More informationTREATMENT. Reviews. Clinical features of postherpetic neuralgia The severity of the pain in postherpetic
PATHOPHYSIOLOGY AND TREATMENT 1 Reviews -HERPETIC NEURALGIA: AND TREATMENT Howard L. Fields, M.D., Ph.D.* (JJSPC Vol.6 No.1, 1 `9, 1999) Clinical features of postherpetic neuralgia The severity of the
More informationHerpes Zoster Ophtalmicus in a HIV positive patient: A Case Report
ISPUB.COM The Internet Journal of Neurology Volume 9 Number 2 Herpes Zoster Ophtalmicus in a HIV positive patient: A Case Report G Lopez Bejerano, Y Graza Fernandez Citation G Lopez Bejerano, Y Graza Fernandez..
More informationMicrobiology of the central nervous system PNS. Anas Abu-Humaidan M.D. Ph.D. Lecture 5
Microbiology of the central nervous system PNS Anas Abu-Humaidan M.D. Ph.D. Lecture 5 Peripheral Nervous System Manifestations of Infectious Diseases In general, patients with PNS dysfunction complain
More informationBasic Neuroscience. Sally Curtis
The Physiology of Pain Basic Neuroscience Sally Curtis sac3@soton.ac.uk The behaviour of humans is a result of the actions of nerves. Nerves form the basis of Thoughts, sensations and actions both reflex
More informationPreemptive Analgesia: Does it Prevent Chronic Pain?
Preemptive Analgesia: Does it Prevent Chronic Pain? Prof. Dr. Maged El-Ansary Al Azhar Univ. Al Azhar university, Cairo, Egypt 1. President of Egyptian Society for Regional Anesthesia & Pain Medicine 2.President
More informationNuances of Spinal Radiculopathy. James Mallows
Nuances of Spinal Radiculopathy James Mallows Spinal dermatomes A dermatome is an area of skin that is mainly supplied by a single spinal nerve History of dermatomes Pioneering work by Sherrington (late
More informationNervous system Reflexes and Senses
Nervous system Reflexes and Senses Physiology Lab-4 Wrood Slaim, MSc Department of Pharmacology and Toxicology University of Al-Mustansyria 2017-2018 Nervous System The nervous system is the part of an
More informationPAIN IS A SUBJECTIVE EXPERIENCE: It is not a stimulus. MAJOR FEATURES OF THE PAIN EXPERIENCE: Sensory discriminative Affective (emotional) Cognitive
PAIN PAIN IS A SUBJECTIVE EXPERIENCE: It is not a stimulus MAJOR FEATURES OF THE PAIN EXPERIENCE: Sensory discriminative Affective (emotional) Cognitive MEASUREMENT OF PAIN: A BIG PROBLEM Worst pain ever
More information3/7/2018. IASP updated definition of pain. Nociceptive Pain. Transduction. (Nociceptors) Transmission. (Peripheral nerve) Modulation
IASP updated definition of pain The Pain of Trauma and The Trauma of Pain: The Opioid Crisis is Not What You Think. Bennet Davis, M.D. Many people report pain in the absence of tissue damage or any likely
More information